Home / Diabetes In Control (page 288)

Diabetes In Control

Letter from the Editor #729

On Friday morning after I got done with a 40 mile bike ride with our local club, we were sitting and talking at our favorite coffee shop when my phone rang. It was a family friend who wanted to talk about her husband’s medications for diabetes. He had been referred …

Read More »

Eye Chart Pro

Eye-Chart-Pro-image1

Dok LLC Free/iOS   Eye Chart Pro is a randomizable visual acuity exam, and can be controlled remotely. It’s useful for triaging, house visits, and for those patients who have memorized the office chart. Features include: Randomizable Snellen Chart; Randomizable Tumbling E Chart; Randomize the whole chart or one line at a time; Smooth …

Read More »

Letter from the Editor #728

We have a really interesting item this week that bears reading more than once. Item #4 talks about using glimepiride with patients who are on insulin and how this may be safer and and better than adding more insulin. This article could be turned around to say we should start …

Read More »

U-500 Insulin Pen “Coming Soon”

Humulin-RU-500-Pen-image

U-500 Insulin Pen "Coming Soon"  Because of the many errors reported when using U-500 insulin, Eli Lilly is developing a prefilled pen designed to deliver HUMULIN R U-500 (insulin human), and the company is also working with a development partner on the design of a dedicated U-500 insulin syringe. These …

Read More »

Early Obesity Linked to Severe Obesity Later in Life

Using data from the 1999-2010 U.S. NHANES survey, researchers found that men who were obese at age 25 had a 23.1% estimated probability of class III obesity (defined as a BMI greater than 40) after age 35, while men of a normal weight at age 25 only had a 1.1% …

Read More »

Exenatide Beneficial for Parkinson’s Disease (PD)

A follow-up study of patients with PD who participated in an earlier "proof of concept" clinical trial using exenatide showed that improvements persisted twelve months after discontinuing exenatide therapy. Several recent discoveries have highlighted common cellular pathways that potentially relate neurodegenerative processes with abnormal mitochondrial function and abnormal glucose metabolism. …

Read More »

Medical Homes Can Reduce Costs for People with Diabetes by 21%

A study revealed diabetes patients who received care at a patient-centered medical home attained a 21% reduction in health costs at one year. Researchers also noted a 34% decrease in emergency department visits, an 18% drop in specialist visits, and a 32% cut in outpatient care costs. Researchers analyzed nearly …

Read More »